Navigation Links
The Use Of Implants After Breast Cancer Questioned

A new study shows choosing to have implants after a mastectomy does not reduce the long-term survival of the patient. Researchers say they found that women with implants had a better chance of survival than those who did not have implants.//

Researchers speculate that the implants may boost the morale and self-esteem of the patient, which could improve their survival. Some studies have suggested that breast implants could stimulate the immune system and reduce blood flow to the breast, thereby impairing cell and tumor growth.

Previous research has shown that breast implants do not have a negative impact on a cancer patient’s health in the short term. However, long-term studies have not been done. A more recent study done included more than 4,000 women under age 65 who were diagnosed with early stage breast cancer. All of the women had a mastectomy, and some opted to have a breast implant. Researchers say out of the 21 percent of the women who had a breast implant, about 12 percent died from their breast cancer. However, of the women who did not have an implant, about 19 percent died from their breast cancer during the study. After controlling for other factors, researchers conclude that breast cancer mortality in patients with breast implants is about half that of patients without implants.

Thus researchers conclude saying that further study is needed to explain the apparent benefit of breast implants for breast cancer patients.
'"/>




Page: 1

Related medicine news :

1. Breast Implants May Interfere With The Interpretation Of Mammogram Results
2. Implants In The Ear Is Effective Against All Types Of Hearing Loss
3. Scientists Find Way To Stop Infection Of Implants
4. Early Cochlear Implants Prove To Be Effective
5. Cell Implants May Help Those Who Suffer From Parkinsons
6. Uncontrolled Diabetes Spells Doom for Dental Implants
7. Silicone Implants Make No Significant Difference To Breast Cancer Survivors
8. Inner Ear Implants: Cure for Stammerers
9. Potentially Dangerous levels of Platinum Found in Women with Silicone Gel Breast Implants
10. Silicone Leaks Seen Among Women with Breast Implants
11. Earlier the Cochlear Implants Used Better the Speech
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/27/2017)... Farmingdale, NY (PRWEB) , ... March 27, 2017 ... ... specializing in epigenetic research products enables researchers to pursue the recent RNA methylation ... RNA methylation . In light of the newfound characteristics of N6-methyladenosine, or ...
(Date:3/27/2017)... ... March 27, 2017 , ... The Association of Healthcare ... will hold their first Northeast Regional AHVAP Meeting. For 2017, Dr. Hayes will ... chain and value analysis professionals have a ‘seat at the table’ with clinical ...
(Date:3/27/2017)... ... ... According to the American Cancer Society , the average 15-year survival ... the cancer spreads to other organs, bones, or lymph nodes, however, the 5-year survival ... latter group, tune in to Lifestyle Magazine on April 9, 2017, to ...
(Date:3/27/2017)... , ... March 27, 2017 , ... ... Conventional sodium testing methods are complicated and require expert user knowledge. In a ... analytical method dedicated to the simplified, yet highly accurate, determination of sodium. , ...
(Date:3/27/2017)... ... March 27, 2017 , ... ... agreement to resolve the pending litigation between itself and 1800 Vending DBA Healthy ... Utah). , “I am thrilled to announce that we have now reached a ...
Breaking Medicine News(10 mins):
(Date:3/27/2017)... and BOSTON , March 27, ... global pharmaceutical company and Paratek Pharmaceuticals, Inc. (Nasdaq: ... and commercialization of innovative therapies based upon tetracycline ... of sarecycline for the treatment of moderate to ... endpoints. Sarecycline is a once-daily, oral, narrow spectrum ...
(Date:3/27/2017)... Calif. , March 27, 2017  Impax Laboratories, ... has appointed Paul M. Bisaro as Impax,s ... the Company,s Board, effective March 27, 2017. Mr. Bisaro ... served as Interim President and Chief Executive Officer since ... of generic and branded pharmaceutical experience, Mr. Bisaro, 56, ...
(Date:3/27/2017)... -- PhaseRx, Inc. (NASDAQ: PZRX), a biopharmaceutical company developing ... children, today reported financial results for the fourth ... and provided an update on its corporate activities. ... during the fourth quarter of 2016 through the ... study, and with our lead development candidate, PRX-OTC, ...
Breaking Medicine Technology: